[1]
2025. Unveiling the synergistic power of 3-hydrazinoquinoxaline-2-thiol and vancomycin against MRSA: An in vitro and in silico evaluation. Biomolecules and Biomedicine. (Apr. 2025). DOI:https://doi.org/10.17305/bb.2025.11886.